Latin America Contraceptives Market Research Report – Segmented By Drug Type, Medical Devices, End-Users, Country (Mexico, Brazil, Argentina, Chile and Rest of Latin America) - Industry Analysis 2026 to 2034

ID: 1158
Pages: 136

Market Size, 2025

$3.54 Bn

Market Estimate, 2026

$3.77 Bn

Market Forecast, 2034

$6.26 Bn

CAGR, 2026–2034

6.55%

Latin American Contraceptives Market Size

The Latin American Contraceptives Market is projected to grow from USD 3.54 billion in 2025 to USD 3.77 billion in 2026 and reach USD 6.26 billion by 2034, registering a CAGR of 6.55% during the forecast period from 2026 to 2034.

MARKET DRIVERS

Latin America's contraceptives market is projected to grow rapidly due to the presence of massive untapped opportunities, economic development, continually improving healthcare infrastructure, and rising patient awareness.

Contraception is the prevention of pregnancy by interfering with the process of ovulation, implantation, and fertilization through the use of drugs, barriers, medical devices, surgical techniques. They are the drugs that will inhibit sexually transmitted diseases.

The factors influencing the growth of the Latin American market are the growing development of capable female contraceptive devices and drugs, advancement in technologies, increasing initiatives from the government and NGOs to promote contraceptives.

Side effects associated with contraceptive devices and drugs and the rising prevalence of infertility are the restraints hampering the growth of the Latin American contraceptives market.

KEY MARKET PLAYERS

Companies playing a major role in the Latin American contraceptives market profiled in this report are Bayer HealthCare AG, Teva Pharmaceutical Industries Limited, Medisafe Distribution Inc, Pace Pharmaceuticals Inc., Medicines360, Church & Dwight, Co., Inc., Actavis, Inc., CooperSurgical, Inc., Merck & Co., Inc., Reckitt Benckiser plc, Mayer Laboratories, Inc., and Pfizer, Inc.

MARKET SEGMENTATION

This research report on the Latin American contraceptives market has been segmented & sub-segmented into the following categories

By Drug Type

  • Contraceptive Pills
  • Topical Contraceptives
  • Contraceptive Injectable
  • Others (Contraceptive Gels, Jellies, and Creams)

By Medical Devices

  • Male Contraceptive Devices (Condoms)
  • Female Contraceptive Devices
  • Contraceptive Sponges
  • Contraceptive Diaphragms
  • Subdermal Contraceptive Implants
  • Contraceptive Patches
  • Non-Surgical Permanent Contraceptive Devices

By End User

  • Hospitals
  • Home Care
  • Clinics
  • Ambulatory Surgical Centres

By Country

  • Mexico
  • Brazil
  • Argentina
  • Chile
  • Rest of Latin America

Trusted by 500+ companies. We respect your privacy and never share your data.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1600

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: sales@marketdataforecast.com

Click for Request Sample